Top

In Vitro Fertilization (IVF) Market by Cycle Type (Fresh, Thawed IVF and Donor Egg IVF Cycle) and End User (Fertility Clinics, Hospitals, Surgical Centres and Clinical Research Institutes)

Global Opportunity Analysis and Industry Forecast, 2014 - 2022
Category : Diagnostic and Biotech  | Published Date : Aug-2016 | Pages : 414
enquire Customize Report GET DISCOUNT

In vitro fertilization (IVF) is the process of artificial fertilization which happens outside the women’s body. The egg of the women is surgical removed and are fertilized by a sperm in a laboratory. In vitro fertilization is mainly used by women having a problem in conceiving. However, IVF does not always result in pregnancy and success rate varies from individual to individual. IVF procedures have emerged as a preferable choice for the fertility treatments in clinical industry. The market is poised to witness a remarkable growth, primarily due to the related technological advancements such as pre-implantation genetic diagnosis (PGD) and three-parent IVF procedures.

The world IVF market accounted for $9,015 million in 2015 and is projected to garner revenues worth $17,714 million by 2022, registering a CAGR of 10.2% over the forecast period. The growth of the market is attributed to the reduced conceiving rates, delayed pregnancy, changing lifestyle conditions and fertility disorders are the major factors that drive the market growth. Other factors such as favourable reimbursement scenario and delayed parenthood opted by couples due to professional and financial constraints will also help in the growth of the market. On the other hand, barriers such as ethical concerns in particular countries with respect to IVF, high cost of the IVF procedures followed by low awareness, especially in under-developed economies such as Nigeria are likely to restrain the market growth.

Rising initiatives towards commercialization of cost-efficient treatments and emerging medical tourism, mainly in developing nations would offer lucrative growth opportunities for IVF service providers in future. Further, the growing clinical research initiatives for the development of novel IVF technologies would provide a platform for growth of the global IVF market.

The world IVF market is segmented on the basis of cycle type, end users and geography. Based on cycle types, the market is segmented into fresh cycle (non-donor), thawed IVF cycle (non-donor) and donor egg IVF cycles. Fresh cycle (non-donor) is both the highest revenue generating segment as well as the highest growing segment as it is the most commonly adopted method in a IVF process due to high success rate. Similarly, by end users, the market is further segmented into fertility clinics, hospitals, surgical centers and clinical research institutes. In terms of geography, the market is segmented into North America, Europe, Asia-Pacific (APAC) and Latin America, Middle East and Africa (LAMEA).

The Europe IVF market is the leading region in terms of revenue, whereas Asia Pacific is the fastest growing region, owing to growing demand for IVF processes. In terms of number of IVF cycles performed, the Asia-Pacific region dominates the global IVF market. Asia Pacific IVF market is set to grow at a promising CAGR of 13.3% from 2016 to 2022, due to factors such as wide availability of IVF clinics, high IVF success rates and the rising trend of fertility tourism. In Asia-Pacific region, Japan is the leading country accounting for majority of the market share and is expected to maintain its position throughout the analysis period.

KEY BENEFITS FOR STAKEHOLDERS:

  • The report provides an in-depth analysis of the IVF market across major countries with a cross sectional analysis of the number of IVF cycles performed, and total revenue generated during the forecast period
  • The report helps in understanding the strategies adopted by various IVF clinics and hospitals, in order to gain a higher market share in the global IVF market
  • Region-wise and country-wise share in the global IVF market is comprehensively analyzed in the report
  • The projections in the report are made by analyzing the current market trends and highlighting the market potential for the period of 2014-2022, in terms of value and volume
  • The study provides an in-depth analysis of the world IVF Services market with current trends and future estimations to elucidate the imminent investment pockets.

KEY MARKET SEGMENTS:

Market by End Users

  • Fertility Clinics
  • Hospitals
  • Surgical centers
  • Clinical research institutes

Market, By Geography

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • United Kingdom
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Russia
    • Others Europe
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • New Zealand
    • Korea
    • Thailand
    • Others APAC
  • LAMEA
    • Latin America
    • Middle East
    • Africa

CHAPTER 1 INTRODUCTION

1.1 Report Description
1.2 Key Benefits
1.3 Key Market Segments
1.4 Research Methodology

1.4.1 Secondary research
1.4.2 Primary research
1.4.3 Analyst tools and models

CHAPTER 2 EXECUTIVE SUMMARY

CHAPTER 3 WORLD IN VITRO FERTILIZATION (IVF) MARKET OVERVIEW

3.1 Market Definition and Scope
3.2 IVF Pricing Trends, By Country
3.3 IVF Cycles, By Country
3.4 Global IVF Market, by End User

3.4.1 Fertility Clinics
3.4.2 Hospitals
3.4.3 Surgical Centers
3.4.4 Clinical Research Institutes

3.5 Global IVF Market by Cycle Type

3.5.1 Fresh IVF Cycles (Non-donor)
3.5.2 Thawed IVF Cycles (Non-donor)
3.5.3 Donor Egg IVF Cycles

3.6 Market Dynamics

3.6.1 Drivers

3.6.1.1 Delayed pregnancy
3.6.1.2 Rise in global infertility rates
3.6.1.3 Emergence of new fertility tourism destinations

3.6.2 Restraints

3.6.2.1 High Cost involved in treatment
3.6.2.2 Low level of awareness in developing economies
3.6.2.3 Inadequate reimbursements policies for IVF treatments
3.6.2.4 Ethical Considerations

3.6.3 Opportunities

3.6.3.1 relaxation of legal considerations on ivf treatments
3.6.3.2 New technology development and treatment options
3.6.3.3 Three parent IVF

3.7 Key Findings

CHAPTER 4 NORTH AMERICAN IVF MARKET

4.1 U.S.: IVF Market, (Revenue and Number of Cycles)

4.1.1 Number of Infertility Clinics, 2015
4.1.2 U.S. IVF Market, by End Users

4.1.2.1 Fertility clinics
4.1.2.2 Hospitals
4.1.2.3 Surgical centers
4.1.2.4 Clinical research institutes

4.1.3 U.S. IVF Market, by Cycle Type

4.1.3.1 Fresh IVF cycles (non-donor)
4.1.3.2 Thawed IVF cycles (non-donor)
4.1.3.3 Donor egg IVF cycles

4.1.4 Drivers

4.1.4.1 Increasing popularity of IVF in the U.S.
4.1.4.2 Increased rate of infertility and practices of embryo banking cycles

4.1.5 Restraints

4.1.5.1 High cost of IVF treatments in the U.S.
4.1.5.2 Restrictions on three-parent IVF treatments
4.1.5.3 Scattered Reimbursements

4.1.6 Regulatory Issues, Legislations, and Authorities
4.1.7 Insurance Reimbursement Scenario
4.1.8 Company Profile

4.1.8.1 Fertility and Gynecology Center Monterey Bay IVF
4.1.8.2 Conceptions Reproductive Associates
4.1.8.3 Servy Massey Fertility Institute
4.1.8.4 Sher Institute for Reproductive Medicine (SIRM)
4.1.8.5 Cardone Reproductive Medicine & Infertility
4.1.8.6 Fertility Center of San Antonio
4.1.8.7 Houston Fertility Center
4.1.8.8 New hope fertility center
4.1.8.9 Reproductive Medicine Associates Of New Jersey

4.2 Canada IVF Market (Revenue and Number of Cycles)

4.2.1 Number of Infertility Centers
4.2.2 Canadian IVF Market, by End User

4.2.2.1 Fertility clinics
4.2.2.2 Hospitals
4.2.2.3 Surgical centers
4.2.2.4 Clinical research institutes

4.2.3 Canadian IVF Market, By Cycle Type

4.2.3.1 Fresh IVF cycles (non-donor)
4.2.3.2 Thawed IVF cycles (non-donor)
4.2.3.3 Donor egg IVF cycles

4.2.4 Market Dynamics

4.2.4.1 Drivers

4.2.4.1.1 COMMERCIALIZATION OF IVF BOOSTER IN CANADA

4.2.4.2 Restraints

4.2.4.2.1 HIGH COST OF IVF IN CANADA

4.2.5 Regulatory Issues, Legislations and Authorities
4.2.6 Insurance Reimbursement Scenario
4.2.7 Company Profile

4.2.7.1 Toronto Centre for Advanced Reproductive Technology Ltd.
4.2.7.2 Fertility Treatment Center
4.2.7.3 Montreal Fertility Center

4.3 Mexican IVF Market (Revenue and Number of Cycles)

4.3.1 Number of Infertility Centers
4.3.2 Mexico IVF Market by End Users

4.3.2.1 Fertility clinics
4.3.2.2 Hospitals
4.3.2.3 Surgical centers
4.3.2.4 Clinical research institutes

4.3.3 Mexico IVF market by cycle type

4.3.3.1 Fresh IVF cycles (non-donor)
4.3.3.2 Thawed IVF cycles (non-donor)
4.3.3.3 Donor egg IVF cycles

4.3.4 Market Dynamics

4.3.4.1 Drivers

4.3.4.1.1 FERTILITY TOURISM
4.3.4.1.2 COMPARATIVELY LOW COST OF IVF

4.3.4.2 Restraints

4.3.4.2.1 LANGUAGE BARRIERS

4.3.5 Regulatory Issues, Legislations, and Authorities
4.3.6 Insurance Reimbursement Scenario
4.3.7 Company Profile

4.3.7.1 Liv Fertility Center In Puerto Vallarta
4.3.7.2 BFC Biofertility Center

CHAPTER 5 EUROPE IVF MARKET (REVENUE AND NUMBER OF CYCLES)

5.1 Germany IVF Market (Revenue and Number of Cycles)

5.1.1 Number of infertility clinics in Germany
5.1.2 Germany IVF Market by End User

5.1.2.1 Fertility clinics
5.1.2.2 Hospitals
5.1.2.3 Surgical centers
5.1.2.4 Clinical research institutes

5.1.3 Germany IVF market by cycle type

5.1.3.1 Fresh IVF cycles (non-donor)
5.1.3.2 Thawed IVF cycles (non-donor)

5.1.4 Market Dynamics

5.1.4.1 Drivers

5.1.4.1.1 SUBSIDIZING IVF TREATMENTS
5.1.4.1.2 DELAYED MARRIAGES AND PARENTHOOD DECISIONS

5.1.4.2 Restraints

5.1.4.2.1 LIMITED ADOPTION OF IVF METHODS

5.1.5 Regulatory Issues, Legislations and Authorities
5.1.6 Insurance Reimbursement Scenario
5.1.7 Company Profile

5.1.7.1 Heidelberg University Hospital
5.1.7.2 Klinikum Stuttgart
5.1.7.3 DRK Kliniken Berlin
5.1.7.4 University Medical Center Freiburg

5.2 France IVF Market (Revenue and Number of Cycles)

5.2.1 Number of infertility centers in France
5.2.2 France IVF Market by End User

5.2.2.1 Fertility clinics
5.2.2.2 Hospitals
5.2.2.3 Surgical centers
5.2.2.4 Clinical research institutes

5.2.3 France IVF market by cycle type

5.2.3.1 Fresh IVF cycles (non-donor)
5.2.3.2 Thawed IVF cycles (non-donor)
5.2.3.3 Donor egg IVF cycles

5.2.4 Market Dynamics

5.2.4.1 Drivers

5.2.4.1.1 RISING ADOPTION OF IVF BABIES AMONG SAME GENDER POPULATION
5.2.4.1.2 LOWER RATES OF FERTILITY

5.2.4.2 Restraints

5.2.4.2.1 STRINGENT GOVERNMENT REGULATIONS

5.2.5 Regulatory Issues, Legislations, and Authorities
5.2.6 Insurance Reimbursement Scenario
5.2.7 Company Profile

5.2.7.1 Clinique de la Muette
5.2.7.2 Hopital des metallurgists, hopital cochin

5.3 UK IVF Market (Revenue and Number of Cycles)

5.3.1 Number of infertility centers in UK
5.3.2 UK IVF Market by End User

5.3.2.1 Fertility clinics
5.3.2.2 Hospitals
5.3.2.3 Surgical centers
5.3.2.4 Clinical research institutes

5.3.3 UK IVF market by cycle type

5.3.3.1 Fresh IVF cycles (non-donor)
5.3.3.2 Thawed IVF cycles (non-donor)
5.3.3.3 Donor egg IVF cycles

5.3.4 Drivers

5.3.4.1 Commercialization of three-parent IVF procedures
5.3.4.2 Supportive Regulations

5.3.5 Restraints

5.3.5.1 Ethical Considerations

5.3.6 Regulatory Issues, Legislations and Authorities
5.3.7 Insurance Reimbursement Scenario
5.3.8 Company Profile

5.3.8.1 Lister Fertility Clinic
5.3.8.2 The Bridge Center
5.3.8.3 Chelsea and Westminster Hospital (Assisted Conception Unit)

5.4 Italy IVF Market (Revenue and Number of Cycles)

5.4.1 Italy IVF market by End users

5.4.1.1 Fertility clinics
5.4.1.2 Hospitals
5.4.1.3 Surgical centers
5.4.1.4 Clinical research institutes

5.4.2 Italy IVF market by cycle type

5.4.2.1 Fresh IVF cycles (non-donor)
5.4.2.2 Thawed IVF cycles (non-donor)

5.4.3 Market Dynamics

5.4.3.1 Drivers
5.4.3.2 Restraints

5.4.3.2.1 BAN ON SURROGACY

5.4.4 Regulatory issues, legislations and authorities
5.4.5 Insurance Reimbursement Scenario
5.4.6 Company Profile

5.4.6.1 ARC-STER srl
5.4.6.2 RAPRUI
5.4.6.3 Centre for Reproductive Medicine-Napoli

5.5 Spain IVF Market (Revenue and Number of Cycles)

5.5.1 Spain IVF Market by End Users

5.5.1.1 Fertility clinics
5.5.1.2 Hospitals
5.5.1.3 Surgical centers
5.5.1.4 Clinical research institutes

5.5.2 Spain IVF Market by Cycle Type

5.5.2.1 Fresh IVF cycles (non-donor)
5.5.2.2 Thawed IVF cycles (non-donor)
5.5.2.3 Donor egg IVF cycles

5.5.3 Market Dynamics

5.5.3.1 Drivers

5.5.3.1.1 INCREASE IN THE NUMBER OF FOREIGN PATIENTS

5.5.3.2 Restraints

5.5.4 Regulatory Issues, Legislations and Authorities
5.5.5 Insurance Reimbursement Scenario
5.5.6 Company Profiles

5.5.6.1 IVF spain
5.5.6.2 Clnica EUGIN Barcelona

5.6 Denmark IVF Market (Revenue and Number Of Cycles)

5.6.1 Denmark IVF Market by End Users

5.6.1.1 Fertility clinics
5.6.1.2 Hospitals
5.6.1.3 Surgical centers
5.6.1.4 Clinical research institutes

5.6.2 Denmark IVF market by cycle type

5.6.2.1 Fresh IVF cycles (non-donor)
5.6.2.2 Thawed IVF cycles (non-donor)
5.6.2.3 Donor egg IVF cycles

5.6.3 Drivers

5.6.3.1 Increase in disposable income
5.6.3.2 Advances in IVF technology

5.6.4 Restraints
5.6.5 Regulatory Issues, Legislations and Authorities
5.6.6 Insurance Reimbursement Scenario
5.6.7 Company Profiles

5.6.7.1 Copenhagen Fertility Center
5.6.7.2 Storkklinik v/Nina Stork
5.6.7.3 Vitanova
5.6.7.4 trianglen fertility clinic
5.6.7.5 Nordica - Denmark, Copenhagen

5.7 Russia IVF Market (Revenue and Number of Cycles)

5.7.1 Russia IVF Market by End Users

5.7.1.1 Fertility clinics
5.7.1.2 Hospitals
5.7.1.3 Surgical centers
5.7.1.4 Clinical research institutes

5.7.2 Russia IVF market by cycle type

5.7.2.1 Fresh IVF cycles (non-donor)
5.7.2.2 Thawed IVF cycles (non-donor)
5.7.2.3 Donor egg IVF cycles

5.7.3 Drivers

5.7.3.1 Rising popularity of fertility tourism

5.7.4 Restraints

5.7.4.1 Inadequate reimbursement policies

5.7.5 Regulatory Issues, Legislations, and Authorities
5.7.6 Insurance Reimbursement Scenario
5.7.7 Company Profiles

5.7.7.1 ava-peter clinic
5.7.7.2 md medical group
5.7.7.3 ivf russia (The International Centre of the Reproductive Medicines)

5.8 Rest of Europe IVF Market (Revenue and Number of Cycles)

5.8.1 Rest of Europe IVF Market by End User

5.8.1.1 Fertility clinics
5.8.1.2 Hospitals
5.8.1.3 Surgical centers
5.8.1.4 Clinical research institutes

5.8.2 Drivers

5.8.2.1 Wide availability of reimbursements
5.8.2.2 Changes in Lifestyle

5.8.3 Restraints
5.8.4 Regulatory Issues, Legislations and Authorities
5.8.5 Insurance Reimbursement Scenario
5.8.6 Company Profiles

5.8.6.1 Gynaecoloqisch Centrum
5.8.6.2 centrum voor medische genetica
5.8.6.3 Infertility-Vestliitto

CHAPTER 6 ASIA-PACIFIC IVF MARKET (REVENUE AND NUMBER OF CYCLES)

6.1 India IVF Market (Revenue and Number of Cycles)

6.1.1 India IVF Market by End Users

6.1.1.1 Fertility clinics
6.1.1.2 Hospitals
6.1.1.3 Surgical centers
6.1.1.4 Clinical research institutes

6.1.2 India IVF market by cycle type

6.1.2.1 Fresh IVF cycles (non-donor)
6.1.2.2 Thawed IVF cycles (non-donor)
6.1.2.3 Donor egg IVF cycles

6.1.3 Market Dynamics

6.1.3.1 Drivers
6.1.3.2 Restraints

6.1.4 Regulatory Issues, Legislations and Authorities
6.1.5 Insurance Reimbursement Scenario
6.1.6 Company Profile

6.1.6.1 Bourn Hall Clinic
6.1.6.2 Southend Fertility and IVF Centre
6.1.6.3 Morpheus IVF Fertility Center
6.1.6.4 Bloom Fertility Center
6.1.6.5 Manipal Ankur
6.1.6.6 Cloudnine
6.1.6.7 Nova IVI Fertility

6.2 China IVF Market (Revenue and Number of Cycles)

6.2.1 China IVF Market by End User

6.2.1.1 Fertility clinics
6.2.1.2 Hospitals
6.2.1.3 Surgical centers
6.2.1.4 Clinical research institutes

6.2.2 China IVF market by cycle type

6.2.2.1 Fresh IVF cycles (non-donor)
6.2.2.2 Thawed IVF cycles (non-donor)
6.2.2.3 Donor egg IVF cycles

6.2.3 Market Dynamics

6.2.3.1 Drivers

6.2.3.1.1 CHANGE IN LIFESTYLE

6.2.3.2 Restraints

6.2.3.2.1 ONE CHILD POLICY

6.2.4 Regulatory Issues, Legislations and Authorities
6.2.5 Insurance Reimbursement Scenario
6.2.6 Company profile

6.2.6.1 Reproductive and genetic Hospital Citic-Xiangya
6.2.6.2 Shenyang Hospital
6.2.6.3 Shandong Provincial Hospital
6.2.6.4 Centre for Reproductive Medicine

6.3 Japan IVF Market (Revenue and Number of Cycles)

6.3.1 Japan IVF Market by End User

6.3.1.1 Fertility clinics
6.3.1.2 Hospitals
6.3.1.3 Surgical centers
6.3.1.4 Clinical research institutes

6.3.2 Japan IVF Market by Cycle Type

6.3.2.1 Fresh IVF cycles (non-donor)
6.3.2.2 Thawed IVF cycles (non-donor)

6.3.3 Market Dynamics

6.3.3.1 Drivers
6.3.3.2 Restraints

6.3.4 Regulatory Issues, Legislations, and Authorities
6.3.5 Insurance Reimbursement Scenario
6.3.6 Company Profile

6.3.6.1 EMD Serono, Inc.
6.3.6.2 IVF NAMBA Clinic
6.3.6.3 Iwaki Womens Clinic
6.3.6.4 Sanno Hospital

6.4 Australia IVF Market (Revenue and Number of Cycles)

6.4.1 Australia IVF Market by End User

6.4.1.1 Fertility clinics
6.4.1.2 Hospitals
6.4.1.3 Surgical centers
6.4.1.4 Clinical research institutes

6.4.2 Australia IVF Market by Cycle Type

6.4.2.1 Fresh IVF cycles (non-donor)
6.4.2.2 Thawed IVF cycles (non-donor)

6.4.3 Market Dynamics

6.4.3.1 Drivers
6.4.3.2 Restraints

6.4.3.2.1 EMOTIONAL AND PHYSICAL STRESS
6.4.3.2.2 NO GUARANTEE FOR THE SUCCESSFUL TREATMENTS
6.4.3.2.3 SURPLUS EMBRYOS

6.4.4 Regulatory Issues, Legislations, and Authorities
6.4.5 Insurance Reimbursement Scenario
6.4.6 Company Profile

6.4.6.1 Genea Biomedx
6.4.6.2 Thermo Fisher Scientific Inc.
6.4.6.3 Virtus Health limited
6.4.6.4 Monash IVF
6.4.6.5 City Fertility center, brisbane
6.4.6.6 Flinders Fertility clinic

6.5 New Zealand IVF Market (Revenue and Number of Cycles)

6.5.1 New Zealand IVF Market by End User

6.5.1.1 Fertility clinics
6.5.1.2 Hospitals
6.5.1.3 Surgical centers
6.5.1.4 Clinical research institutes

6.5.2 New Zealand IVF Market by Cycle Type

6.5.2.1 Fresh IVF cycles (non-donor)
6.5.2.2 Thawed IVF cycles (non-donor)
6.5.2.3 Donor egg IVF cycles

6.5.3 Market Dynamics

6.5.3.1 Drivers
6.5.3.2 Restraints

6.5.4 Regulatory Issues, Legislations, and Authorities
6.5.5 Insurance Reimbursement Scenario
6.5.6 Company Profiles

6.5.6.1 Fertility Associates
6.5.6.2 Fertility Plus
6.5.6.3 Repromed

6.6 Korea IVF Market (Revenue and Number of Cycles)

6.6.1 Korea IVF Market by End User

6.6.1.1 Fertility clinics
6.6.1.2 Hospitals
6.6.1.3 Surgical centers
6.6.1.4 Clinical research institutes

6.6.2 Korea IVF market by cycle type

6.6.2.1 Fresh IVF cycles (non-donor)
6.6.2.2 Thawed IVF cycles (non-donor)
6.6.2.3 Donor egg IVF cycles

6.6.3 Market Dynamics

6.6.3.1 Drivers
6.6.3.2 Restraints

6.6.4 Regulatory Issues, Legislations, and Authorities
6.6.5 Insurance Reimbursement Scenario
6.6.6 Company Profiles

6.6.6.1 Cha General Hospital
6.6.6.2 MARIA Fertility Hospital

6.7 Thailand IVF Market (Revenue and number of Cycles)

6.7.1 Thailand IVF Market by End User

6.7.1.1 Fertility clinics
6.7.1.2 Hospitals
6.7.1.3 Surgical centers
6.7.1.4 Clinical research institutes

6.7.2 Thailand IVF Market by Cycle Type

6.7.2.1 Fresh IVF cycles (non-donor)
6.7.2.2 Thawed IVF cycles (non-donor)
6.7.2.3 Donor egg IVF cycles

6.7.3 Market Dynamics

6.7.3.1 Drivers

6.7.3.1.1 GOVERNMENT INITIATIVES
6.7.3.1.2 ECONOMIC CONSIDERATIONS
6.7.3.1.3 BOOST IN MEDICAL TOURISM

6.7.3.2 Restraints

6.7.3.2.1 COMPARATIVELY LOW SUCCESS RATE
6.7.3.2.2 ETHICAL ISSUES IN ALLOWING GENDER SELECTION

6.7.4 Regulatory Issues, Legislations, and Authorities
6.7.5 Insurance Reimbursement Scenario
6.7.6 Company Profiles

6.7.6.1 Bangkok Fertility Center
6.7.6.2 Siriraj Hospital
6.7.6.3 Ramathibodi Hospital
6.7.6.4 Perfect Woman Institute
6.7.6.5 Jetanin Institute for Assisted Reproduction

6.8 Rest of Asia-Pacific IVF Market (Revenue and Number of Cycles)

6.8.1 Rest of Asia-Pacific IVF Market by End User

6.8.1.1 Fertility clinics
6.8.1.2 Hospitals
6.8.1.3 Surgical centers
6.8.1.4 Clinical research institutes

6.8.2 Drivers

6.8.2.1 Increase in disposable income
6.8.2.2 Advances in IVF technology
6.8.2.3 Decline in fertility rate

6.8.3 Restraints

6.8.3.1 Physical and emotional impact due to low success rate

6.8.4 Regulatory Issues, Legislations, and Authorities
6.8.5 Insurance Reimbursement Scenario
6.8.6 Company Profiles

6.8.6.1 Fertility Centre, Siloam Hospitals Surabana
6.8.6.2 CRM-MIA-Philippines
6.8.6.3 IVFAS

CHAPTER 7 LAMEA IVF MARKET (REVENUE AND NUMBER OF CYCLES)

7.1 Latin America IVF Market (Revenue and Number of Cycles)

7.1.1 Number of Infertility Centers
7.1.2 Latin America IVF Market by End User

7.1.2.1 Fertility clinics
7.1.2.2 Hospitals
7.1.2.3 Surgical centers
7.1.2.4 Clinical research institutes

7.1.3 Latin America IVF market by cycle type

7.1.3.1 Fresh IVF cycles (non-donor)
7.1.3.2 Thawed IVF cycles (non-donor)
7.1.3.3 Donor egg IVF cycles

7.1.4 Drivers

7.1.4.1 Rising Medical Tourism in Latin America
7.1.4.2 Permission for IVF treatments in Costa Rica

7.1.5 Restraints

7.1.5.1 High infant mortality rates in Brazil

7.1.6 Regulatory Issues, Legislations, and Authorities
7.1.7 Insurance Reimbursement Scenario
7.1.8 Profiles of Major Players

7.1.8.1 Clinica Anglo Americana
7.1.8.2 IVF Panama Centro De Reproduccion
7.1.8.3 Insemer
7.1.8.4 Almater Hospital
7.1.8.5 San Fernando Hospital

7.2 Middle East IVF Market (Revenue and Number of Cycles)

7.2.1 Number of Infertility Centers
7.2.2 Middle East IVF Market by End User

7.2.2.1 Fertility clinics
7.2.2.2 Hospitals
7.2.2.3 Surgical centers
7.2.2.4 Clinical research institutes

7.2.3 Middle East IVF Market by Cycle Type

7.2.3.1 Fresh IVF cycles (non-donor)
7.2.3.2 Thawed IVF cycles (non-donor)
7.2.3.3 Donor egg IVF cycles

7.2.4 Market Dynamics

7.2.4.1 Drivers

7.2.4.1.1 HIGH-TECH CULTURE
7.2.4.1.2 AVAILABILITY OF REIMBURSEMENTS

7.2.4.2 Restraints

7.2.4.2.1 STRINGENT GOVERNMENT REGULATIONS

7.2.5 Regulatory Issues, Legislations, and Authorities
7.2.6 Insurance Reimbursement Scenario
7.2.7 Company Profile

7.2.7.1 Cyprus IVF Centre
7.2.7.2 Al Bushra Medical Specialty Complex
7.2.7.3 Reproductive Medicine Unit at Corniche Hospital (Corniche Fertility center)
7.2.7.4 Trakya University Hospital ART Center

7.3 Africa IVF Market (Revenue and Number of Cycles)

7.3.1 Number of Infertility Centers
7.3.2 Africa IVF Market by End User

7.3.2.1 Fertility clinics
7.3.2.2 Hospitals
7.3.2.3 Surgical centers
7.3.2.4 Clinical research institutes

7.3.3 Africa IVF Market by Cycle Type

7.3.3.1 Fresh IVF cycles (non-donor)
7.3.3.2 Thawed IVF cycles (non-donor)
7.3.3.3 Donor egg IVF cycles

7.3.4 Drivers

7.3.4.1 Low costs of IVF treatment
7.3.4.2 Rising Fertility Tourism in South Africa

7.3.5 Restraints

7.3.5.1 Susceptibility toward fibroids

7.3.6 Regulatory Issues, Legislations, and Authorities
7.3.7 Insurance Reimbursement Scenario
7.3.8 Company Profile

7.3.8.1 Lifesure Fertility & Gynaecology Centre
7.3.8.2 Bethany Women and Family Hospital
7.3.8.3 BioART Fertility Centre
7.3.8.4 DEL International Hospital & Fertility Centre
7.3.8.5 Gift ov life
7.3.8.6 Durban Fertility Clinic
7.3.8.7 Cape fertility clinic

List of Figures

FIG. 1 GLOBAL IVF MARKET, BY FERTILITY CLINICS, VOLUME, AND VALUE, 20142022, (THOUSAND, $MILLION)
FIG. 2 WORLD IVF MARKET, BY HOSPITAL, VOLUME AND VALUE, 20142022, (THOUSAND, $MILLION)
FIG. 3 WORLD IVF MARKET, BY SURGICAL CENTER, VOLUME AND VALUE, 2014-022, (THOUSAND, $MILLION)
FIG. 4 GLOBAL IVF MARKET, BY CLINICAL RESEARCH INSTITUTE, VOLUME AND VALUE, 20142022, (THOUSAND, $MILLION)
FIG. 5 WORLD IVF MARKET, BY FRESH IVF CYCLE, VOLUME AND VALUE, 20142022, (THOUSAND, $MILLION)
FIG. 6 WORLD IVF MARKET, BY THAWED IVF CYCLE, VOLUME AND VALUE, 20142022, (THOUSAND, $MILLION)
FIG. 7 WORLD IVF MARKET, BY DONOR EGG IVF CYCLE, VOLUME AND VALUE, 20142022, (THOUSAND, $MILLION)
FIG. 8 WORLD IVF MARKET, BY GEOGRAPHY, 20152022 ($MILLION)
FIG. 9 WORLD IVF MARKET, BY GEOGRAPHY, 20152022 (THOUSAND)
FIG. 10 U.S. IVF MARKET, BY FERTILITY CLINICS, VOLUME, AND VALUE, 20142022, (THOUSAND, $MILLION)
FIG. 11 U.S. IVF MARKET, BY HOSPITAL, VOLUME AND, VALUE, 20142022, (THOUSAND, $MILLION)
FIG. 12 U.S. IVF MARKET, BY SURGICAL CENTER, 20142022, VOLUME AND VALUE (THOUSAND, $MILLION)
FIG. 13 U.S. IVF MARKET, BY CLINICAL RESEARCH INSTITUTE, VOLUME AND VALUE, 20142022, (THOUSAND, $MILLION)
FIG. 14 U.S. IVF MARKET, BY FRESH IVF CYCLE, VOLUME AND VALUE, 20142022 (THOUSAND, $MILLION)
FIG. 15 U.S. IVF MARKET, BY THAWED IVF CYCLE, VOLUME AND VALUE, 20142022 (THOUSAND, $MILLION)
FIG. 16 U.S. IVF MARKET, BY DONOR EGG IVF CYCLE, VOLUME AND VALUE, 20142022, (THOUSAND, $MILLION)
FIG. 17 ART REGULATORY SCENARIO, U.S.
FIG. 18 CANADIAN IVF MARKET, BY FERTILITY CLINIC, VOLUME AND VALUE, 20142022, (THOUSAND, $MILLION)
FIG. 19 CANADIAN IVF MARKET, BY HOSPITAL, VOLUME AND VALUE, 20142022, (THOUSAND, $MILLION)
FIG. 20 CANADIAN IVF MARKET, BY SURGICAL CENTER, VOLUME AND VALUE, 20142022, (THOUSAND, $MILLION)
FIG. 21 CANADIAN IVF MARKET, BY CLINICAL RESEARCH INSTITUTE, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
FIG. 22 CANADIAN IVF MARKET, BY FRESH IVF CYCLE, VOLUME AND VALUE, 20142022, (THOUSAND, $MILLION)
FIG. 23 CANADIAN IVF MARKET, BY THAWED IVF CYCLE, VOLUME AND VALUE, 20142022, (THOUSAND, $MILLION)
FIG. 24 CANADIAN IVF MARKET, BY DONOR EGG IVF CYCLE, VOLUME AND VALUE, 20142022, (THOUSAND, $MILLION)
FIG. 25 ART REGULATORY SCENARIO, CANADA
FIG. 26 MEXICAN IVF MARKET, BY FERTILITY CLINIC, VOLUME AND VALUE, 20142022, (THOUSAND, $MILLION)
FIG. 27 MEXICAN IVF MARKET, BY HOSPITAL, VOLUME AND VALUE, 20142022, (THOUSAND, $MILLION)
FIG. 28 MEXICAN IVF MARKET, BY SURGICAL CENTER, VOLUME AND VALUE, 20142022, (THOUSAND, $MILLION)
FIG. 29 MEXICAN IVF MARKET, BY CLINICAL RESEARCH INSTITUTE, VOLUME AND VALUE, 20142022, (THOUSAND, $MILLION)
FIG. 30 MEXICAN IVF MARKET, BY FRESH IVF CYCLE, VOLUME AND VALUE, 20142022, (THOUSAND, $MILLION)
FIG. 31 MEXICAN IVF MARKET, BY THAWED IVF CYCLE, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
FIG. 32 MEXICAN IVF MARKET, BY DONOR EGG IVF CYCLE, VOLUME AND VALUE, 20142022, (THOUSAND, $MILLION)
FIG. 33 ART REGULATORY SCENARIO, MEXICO
FIG. 34 GERMANY: IVF MARKET, BY FERTILITY CLINICS, VOLUME & VALUE, 20142022, (THOUSAND, $MILLION)
FIG. 35 GERMANY: IVF MARKET, BY HOSPITAL, VOLUME & VALUE, 20142022, (THOUSAND, $MILLION)
FIG. 36 GERMANY: IVF MARKET, BY SURGICAL CENTER, VOLUME & VALUE, 20142022, (THOUSAND, $MILLION)
FIG. 37 GERMANY: IVF MARKET, BY CLINICAL RESEARCH INSTITUTES, VOLUME & VALUE, 20142022, (THOUSAND, $MILLION)
FIG. 38 GERMANY: IVF MARKET, BY FRESH IVF CYCLES, VOLUME & VALUE, 20142022, (THOUSAND, $MILLION)
FIG. 39 GERMANY: IVF MARKET, BY THAWED IVF CYCLES, VOLUME & VALUE, 20142022, (THOUSAND, $MILLION)
FIG. 40 REGULATORY SCENARIO, GERMANY
FIG. 41 FRANCE: IVF MARKET, BY FERTILITY CLINICS, VOLUME AND VALUE, 20142022, (THOUSAND, $MILLION)
FIG. 42 FRANCE: IVF MARKET, BY HOSPITALS, VOLUME & VALUE, 20142022, (THOUSAND, $MILLION)
FIG. 43 FRANCE: IVF MARKET, BY SURGICAL CENTERS, VOLUME & VALUE, 20142022, (THOUSAND, $MILLION)
FIG. 44 FRANCE: IVF MARKET, BY CLINICAL RESEARCH INSTITUTES, VOLUME & VALUE, 20142022, (THOUSAND, $MILLION)
FIG. 45 FRANCE: IVF MARKET, BY FRESH IVF CYCLES, VOLUME & VALUE, 20142022, (THOUSAND, $MILLION)
FIG. 46 FRANCE: IVF MARKET, BY THAWED IVF CYCLES, VOLUME & VALUE, 20142022, (THOUSAND, $MILLION)
FIG. 47 FRANCE: IVF MARKET, BY DONOR EGG IVF CYCLES, VOLUME AND VALUE, 20142022, (THOUSAND, $MILLION)
FIG. 48 REGULATORY SCENARIO, FRANCE
FIG. 49 UK IVF MARKET, BY FERTILITY CLINICS, VOLUME & VALUE, 20142022, (THOUSAND, $MILLION)
FIG. 50 UK IVF MARKET, BY HOSPITALS, VOLUME & VALUE, 20142022, (THOUSAND, $MILLION)
FIG. 51 UK IVF MARKET, BY SURGICAL CENTERS, VOLUME & VALUE, 20142022, (THOUSAND, $MILLION)
FIG. 52 UK IVF MARKET, BY CLINICAL RESEARCH INSTITUTES, VOLUME & VALUE, 20142022, (THOUSAND, $MILLION)
FIG. 53 UK IVF MARKET, BY FRESH IVF CYCLES, VOLUME & VALUE, 20142022, (THOUSAND, $MILLION)
FIG. 54 UK IVF MARKET, BY THAWED IVF CYCLE, VOLUME & VALUE, 20142022, (THOUSAND, $MILLION)
FIG. 55 UK IVF MARKET, BY DONOR EGG IVF CYCLES, VOLUME & VALUE, 20142022, (THOUSAND, $MILLION)
FIG. 56 REGULATORY SCENARIO, UK
FIG. 57 ITALY: IVF MARKET, BY FERTILITY CLINICS, VOLUME & VALUE, 20142022, (THOUSAND, $MILLION)
FIG. 58 ITALY: IVF MARKET, BY HOSPITALS, VOLUME & VALUE, 20142022, (THOUSAND, $MILLION)
FIG. 59 ITALY: IVF MARKET, BY SURGICAL CENTERS, VOLUME & VALUE, 20142022, (THOUSAND, $MILLION)
FIG. 60 ITALY: IVF MARKET, BY CLINICAL RESEARCH INSTITUTES, VOLUME & VALUE, 20142022, (THOUSAND, $MILLION)
FIG. 61 ITALY: IVF MARKET, BY FRESH IVF CYCLES, VOLUME & VALUE, 20142022, (THOUSAND, $MILLION)
FIG. 62 ITALY: IVF MARKET, BY THAWED IVF CYCLES, VOLUME & VALUE, 20142022, (THOUSAND, $MILLION)
FIG. 63 SPAIN: IVF MARKET, BY FERTILITY CLINICS, VOLUME & VALUE, 20142022, (THOUSAND, $MILLION)
FIG. 64 SPAIN: IVF MARKET, BY HOSPITALS, VOLUME & VALUE, 20142022, (THOUSAND, $MILLION)
FIG. 65 SPAIN: IVF MARKET, BY SURGICAL CENTERS, VOLUME & VALUE, 20142022, (THOUSAND, $MILLION)
FIG. 66 SPAIN: IVF MARKET, BY CLINICAL RESEARCH INSTITUTES, VOLUME & VALUE, 20142022, (THOUSAND, $MILLION)
FIG. 67 SPAIN: IVF MARKET, BY FRESH IVF CYCLES, VOLUME & VALUE, 20142022, (THOUSAND, $MILLION)
FIG. 68 SPAIN: IVF MARKET, BY THAWED IVF CYCLES, VOLUME & VALUE, 20142022, (THOUSAND, $MILLION)
FIG. 69 SPAIN: IVF MARKET, BY DONOR EGG IVF CYCLES, VOLUME & VALUE, 20142022, (THOUSAND, $MILLION)
FIG. 70 DENMARK: IVF MARKET, BY FERTILITY CLINICS, VOLUME & VALUE, 20142022, (THOUSAND, $MILLION)
FIG. 71 DENMARK: IVF MARKET, BY HOSPITAL, VOLUME & VALUE, 20142022, (THOUSAND, $MILLION)
FIG. 72 DENMARK: IVF MARKET, BY SURGICAL CENTERS, VOLUME & VALUE, 20142022, (THOUSAND, $MILLION)
FIG. 73 DENMARK: IVF MARKET, BY CLINICAL RESEARCH INSTITUTES, VOLUME & VALUE, 20142022, (THOUSAND, $MILLION)
FIG. 74 DENMARK: IVF MARKET, BY FRESH IVF CYCLES, VOLUME & VALUE, 20142022, (THOUSAND, $MILLION)
FIG. 75 DENMARK: IVF MARKET, BY THAWED IVF CYCLES, VOLUME & VALUE, 20142022, (THOUSAND, $MILLION)
FIG. 76 DENMARK: IVF MARKET, BY DONOR EGG IVF CYCLES, VOLUME & VALUE, 20142022, (THOUSAND, $MILLION)
FIG. 77 RUSSIA: IVF MARKET, BY FERTILITY CLINICS, VOLUME & VALUE, 20142022, (THOUSAND, $MILLION)
FIG. 78 RUSSIA: IVF MARKET, BY HOSPITAL, VOLUME & VALUE, 20142022, (THOUSAND, $MILLION)
FIG. 79 RUSSIA: IVF MARKET, BY SURGICAL CENTERS, VOLUME & VALUE, 20142022, (THOUSAND, $MILLION)
FIG. 80 RUSSIA: IVF MARKET, BY CLINICAL RESEARCH INSTITUTES, VOLUME & VALUE, 20142022, (THOUSAND, $MILLION)
FIG. 81 RUSSIA: IVF MARKET, BY FRESH IVF CYCLES, VOLUME & VALUE, 20142022, (THOUSAND, $MILLION)
FIG. 82 RUSSIA: IVF MARKET, BY THAWED IVF CYCLES, VOLUME & VALUE, 20142022, (THOUSAND, $MILLION)
FIG. 83 RUSSIA: IVF MARKET, BY DONOR EGG IVF CYCLES, VOLUME & VALUE, 20142022, (THOUSAND, $MILLION)
FIG. 84 REST OF EUROPE: IVF MARKET, BY FERTILITY CLINICS, VOLUME & VALUE, 20142022, (THOUSAND, $MILLION)
FIG. 85 REST OF EUROPE: IVF MARKET, BY HOSPITAL, VOLUME & VALUE, 20142022, (THOUSAND, $MILLION)
FIG. 86 REST OF EUROPE: IVF MARKET, BY SURGICAL CENTER, VOLUME & VALUE, 20142022, (THOUSAND, $MILLION)
FIG. 87 REST OF EUROPE: IVF MARKET, BY CLINICAL RESEARCH INSTITUTES, VOLUME & VALUE, 20142022, (THOUSAND, $MILLION)
FIG. 88 INDIA: TOTAL FERTILITY RATE (CHILDREN BORN/ WOMEN)
FIG. 89 INDIA: IVF MARKET, BY FERTILITY CLINICS, VOLUME & VALUE, 20142022, (THOUSAND, $MILLION)
FIG. 90 INDIA: IVF MARKET, BY HOSPITALS, VOLUME & VALUE, 20142022, (THOUSAND, $MILLION)
FIG. 91 INDIA: IVF MARKET, BY SURGICAL CENTERS, VOLUME & VALUE, 20142022, (THOUSAND, $MILLION)
FIG. 92 INDIA: IVF MARKET, BY CLINICAL RESEARCH INSTITUTES, VOLUME & VALUE, 20142022, (THOUSAND, $MILLION)
FIG. 93 INDIA: IVF MARKET, BY FRESH IVF CYCLES, VOLUME & VALUE, 20142022, (THOUSAND, $MILLION)
FIG. 94 INDIA: IVF MARKET, BY THAWED IVF CYCLES, VOLUME & VALUE, 20142022, (THOUSAND, $MILLION)
FIG. 95 INDIA: IVF MARKET, BY DONOR EGG IVF CYCLES, VOLUME & VALUE, 20142022, (THOUSAND, $MILLION)
FIG. 96 CHINA FERTILITY RATE (CHILDREN BORN/WOMEN)
FIG. 97 CHINA: IVF MARKET, BY FERTILITY CLINICS, VOLUME & VALUE, 20142022, (THOUSAND, $MILLION)
FIG. 98 CHINA: IVF MARKET, BY HOSPITALS, VOLUME & VALUE, 20142022, (THOUSAND, $MILLION)
FIG. 99 CHINA: IVF MARKET, BY SURGICAL CENTERS, VOLUME & VALUE, 20142022, (THOUSAND, $MILLION)
FIG. 100 CHINA: IVF MARKET, BY CLINICAL RESEARCH INSTITUTES, VOLUME & VALUE, 20142022, (THOUSAND, $MILLION)
FIG. 101 CHINA: IVF MARKET, BY FRESH IVF CYCLES, VOLUME & VALUE, 20142022, (THOUSAND, $MILLION)
FIG. 102 CHINA: IVF MARKET, BY THAWED IVF CYCLES, VOLUME & VALUE, 20142022, (THOUSAND, $MILLION)
FIG. 103 CHINA: IVF MARKET, BY DONOR EGG IVF CYCLES, VOLUME & VALUE, 20142022, (THOUSAND, $MILLION)
FIG. 104 JAPAN: TOTAL FERTILITY RATE (CHILDREN BORN/WOMEN)
FIG. 105 JAPAN: IVF MARKET, BY FERTILITY CLINICS, VOLUME AND VALUE, 20142022 (THOUSAND, $MILLION)
FIG. 106 JAPAN: IVF MARKET, BY HOSPITALS, VOLUME AND VALUE, 20142022 (THOUSAND, $MILLION)
FIG. 107 JAPAN: IVF MARKET, BY SURGICAL CENTERS, VOLUME AND VALUE, 20142022 (THOUSAND, $MILLION)
FIG. 108 JAPAN: IVF MARKET, BY CLINICAL RESEARCH INSTITUTES, VOLUME AND VALUE, 20142022 (THOUSAND, $MILLION)
FIG. 109 JAPAN: IVF MARKET, BY FRESH IVF CYCLES, VOLUME AND VALUE, 20142022 (THOUSAND, $MILLION)
FIG. 110 JAPAN: IVF MARKET, BY THAWED IVF CYCLES, VOLUME AND VALUE, 20142022 (THOUSAND, $MILLION)
FIG. 111 AUSTRALIA: TOTAL FERTILITY RATE (CHILDREN BORN/WOMEN)
FIG. 112 IVF SUCCESS RATE FOR AUSTRALIA
FIG. 113 AUSTRALIA: IVF MARKET, BY FERTILITY CLINICS, VOLUME AND VALUE, 20142022 (THOUSAND, $MILLION)
FIG. 114 AUSTRALIA: IVF MARKET, BY HOSPITALS, VOLUME AND VALUE, 20142022 (THOUSAND, $MILLION)
FIG. 115 AUSTRALIA: IVF MARKET, BY SURGICAL CENTERS, VOLUME AND VALUE, 20142022 (THOUSAND, $MILLION)
FIG. 116 AUSTRALIA: IVF MARKET, BY CLINICAL RESEARCH INSTITUTES, VOLUME AND VALUE, 20142022 (THOUSAND, $MILLION)
FIG. 117 AUSTRALIA: IVF MARKET, BY FRESH IVF CYCLES, VOLUME AND VALUE, 20142022 (THOUSAND, $MILLION)
FIG. 118 AUSTRALIA: IVF MARKET, BY THAWED IVF CYCLES, VOLUME AND VALUE, 20142022 (THOUSAND, $MILLION)
FIG. 119 NEW ZEALAND: TOTAL FERTILITY RATE (CHILDREN BORN/WOMEN)
FIG. 120 NEW ZEALAND: IVF MARKET, BY FERTILITY CLINICS, VOLUME AND VALUE, 20142022 (THOUSAND, $MILLION)
FIG. 121 NEW ZEALAND: IVF MARKET, BY HOSPITALS, VOLUME AND VALUE, 20142022 (THOUSAND, $MILLION)
FIG. 122 NEW ZEALAND: IVF MARKET, BY SURGICAL CENTERS, VOLUME AND VALUE, 20142022 (THOUSAND, $MILLION)
FIG. 123 NEW ZEALAND: IVF MARKET, BY CLINICAL RESEARCH INSTITUTES, VOLUME AND VALUE, 20142022 (THOUSAND, $MILLION)
FIG. 124 NEW ZEALAND: IVF MARKET, BY FRESH IVF CYCLES, VOLUME AND VALUE, 20142022 (THOUSAND, $MILLION)
FIG. 125 NEW ZEALAND: IVF MARKET, BY THAWED IVF CYCLES, VOLUME AND VALUE, 20142022 (THOUSAND, $MILLION)
FIG. 126 NEW ZEALAND: IVF MARKET, BY DONOR EGG IVF CYCLES, VOLUME AND VALUE, 20142022 (THOUSAND, $MILLION)
FIG. 127 KOREA: TOTAL FERTILITY RATE (CHILDREN BORN/WOMEN)
FIG. 128 KOREA: IVF MARKET, BY FERTILITY CLINICS, VOLUME AND VALUE, 20142022 (THOUSAND, $MILLION)
FIG. 129 KOREA: IVF MARKET, BY HOSPITALS, VOLUME AND VALUE, 20142022 (THOUSAND, $MILLION)
FIG. 130 KOREA: IVF MARKET, BY SURGICAL CENTERS, VOLUME AND VALUE, 2014-2022 (THOUSAND, $MILLION)
FIG. 131 KOREA: IVF MARKET, BY CLINICAL RESEARCH INSTITUTES, VOLUME AND VALUE, 20142022 (THOUSAND, $MILLION)
FIG. 132 KOREA: IVF MARKET, BY FRESH IVF CYCLES, VOLUME AND VALUE, 20142022 (THOUSAND, $MILLION)
FIG. 133 KOREA: IVF MARKET, BY THAWED IVF CYCLES, VOLUME AND VALUE, 20142022 (THOUSAND, $MILLION)
FIG. 134 KOREA: IVF MARKET, BY DONOR EGG IVF CYCLES, VOLUME AND VALUE, 20142022 (THOUSAND, $MILLION)
FIG. 135 THAILAND: IVF MARKET, BY FERTILITY CLINICS, VOLUME AND VALUE, 20142022 (THOUSAND, $MILLION)
FIG. 136 THAILAND: IVF MARKET, BY HOSPITALS, VOLUME AND VALUE, 20142022 (THOUSAND, $MILLION)
FIG. 137 THAILAND: IVF MARKET, BY SURGICAL CENTERS, VOLUME AND VALUE, 20142022 (THOUSAND, $MILLION)
FIG. 138 THAILAND: IVF MARKET, BY CLINICAL RESEARCH INSTITUTES, VOLUME AND VALUE, 20142022 (THOUSAND, $MILLION)
FIG. 139 THAILAND: IVF MARKET, BY FRESH IVF CYCLES, VOLUME AND VALUE, 20142022 (THOUSAND, $MILLION)
FIG. 140 THAILAND: IVF MARKET, BY THAWED IVF CYCLES, VOLUME AND VALUE, 20142022 (THOUSAND, $MILLION)
FIG. 141 THAILAND: IVF MARKET, BY DONOR EGG IVF CYCLES, VOLUME AND VALUE, 20142022 (THOUSAND, $MILLION)
FIG. 142 REST OF ASIA-PACIFIC: IVF MARKET, BY FERTILITY CLINICS, VOLUME AND VALUE, 20142022 (THOUSAND, $MILLION)
FIG. 143 REST OF ASIA-PACIFIC: IVF MARKET, BY HOSPITALS, VOLUME AND VALUE, 20142022 (THOUSAND, $MILLION)
FIG. 144 REST OF ASIA-PACIFIC: IVF MARKET, BY SURGICAL CENTERS, VOLUME AND VALUE, 20142022 (THOUSAND, $MILLION)
FIG. 145 REST OF ASIA-PACIFIC: IVF MARKET, BY CLINICAL RESEARCH INSTITUTES, VOLUME AND VALUE, 20142022 (THOUSAND, $MILLION)
FIG. 146 LATIN AMERICA: IVF MARKET, BY FERTILITY CLINICS, VOLUME AND VALUE, 20142022 (THOUSAND, $MILLION)
FIG. 147 LATIN AMERICA: IVF MARKET, BY HOSPITALS, VOLUME AND VALUE, 20142022 (THOUSAND, $MILLION)
FIG. 148 LATIN AMERICA: IVF MARKET, BY SURGICAL CENTERS, VOLUME AND VALUE, 20142022 (THOUSAND, $MILLION)
FIG. 149 LATIN AMERICA: IVF MARKET, BY CLINICAL RESEARCH INSTITUTES, VOLUME AND VALUE, 20142022 (THOUSAND, $MILLION)
FIG. 150 LATIN AMERICA: IVF MARKET, BY FRESH IVF CYCLES, VOLUME AND VALUE, 20142022 (THOUSAND, $MILLION)
FIG. 151 LATIN AMERICA: IVF MARKET, BY THAWED IVF CYCLES, VOLUME AND VALUE, 20142022 (THOUSAND, $MILLION)
FIG. 152 LATIN AMERICA: IVF MARKET, BY DONOR EGG IVF CYCLES, VOLUME AND VALUE, 20142022 (THOUSAND, $MILLION)
FIG. 153 LATIN AMERICA: ART REGULATORY SCENARIO,
FIG. 154 MIDDLE EAST: IVF MARKET, BY FERTILITY CLINICS, VOLUME AND VALUE, 20142022 (THOUSAND, $MILLION)
FIG. 155 MIDDLE EAST: IVF MARKET, BY HOSPITALS, VOLUME AND VALUE, 20142022 (THOUSAND, $MILLION)
FIG. 156 MIDDLE EAST: IVF MARKET, BY SURGICAL CENTERS, VOLUME AND VALUE, 20142022 (THOUSAND, $MILLION)
FIG. 157 MIDDLE EAST: IVF MARKET, BY CLINICAL RESEARCH INSTITUTES, VOLUME AND VALUE, 20142022 (THOUSAND, $MILLION)
FIG. 158 MIDDLE EAST: IVF MARKET, BY FRESH IVF CYCLES, VOLUME AND VALUE, 20142022 (THOUSAND, $MILLION)
FIG. 159 MIDDLE EAST: IVF MARKET, BY THAWED IVF CYCLES, VOLUME AND VALUE, 20142022 (THOUSAND, $MILLION)
FIG. 160 MIDDLE EAST: IVF MARKET, BY DONOR EGG IVF CYCLES, VOLUME AND VALUE, 20142022 (THOUSAND, $MILLION)
FIG. 161 MIDDLE EAST: ART REGULATORY SCENARIO
FIG. 162 AFRICA: IVF MARKET, BY FERTILITY CLINICS, VOLUME AND VALUE, 20142022 (THOUSAND, $MILLION)
FIG. 163 AFRICA: IVF MARKET, BY HOSPITALS, VOLUME AND VALUE, 20142022 (THOUSAND, $MILLION)
FIG. 164 AFRICA: IVF MARKET, BY SURGICAL CENTERS, VOLUME AND VALUE, 20142022 (THOUSAND, $MILLION)
FIG. 165 AFRICA: IVF MARKET, BY CLINICAL RESEARCH INSTITUTES, VOLUME AND VALUE, 20142022 (THOUSAND, $MILLION)
FIG. 166 AFRICA: IVF MARKET, BY FRESH IVF CYCLES, VOLUME AND VALUE, 20142022 (THOUSAND, $MILLION)
FIG. 167 AFRICA: IVF MARKET, BY THAWED IVF CYCLES, VOLUME AND VALUE, 20142022 (THOUSAND, $MILLION)
FIG. 168 AFRICA: IVF MARKET, BY DONOR EGG IVF CYCLES, VOLUME AND VALUE, 20142022 (THOUSAND, $MILLION)
FIG. 169 AFRICA: ART REGULATORY SCENARIO

List of Tables

TABLE 1 IVF PRICING TRENDS, BY COUNTRY, 2015
TABLE 2 GLOBAL IVF MARKET, BY COUNTRY, 20142022 (THOUSAND)
TABLE 3 GLOBAL IVF MARKET, BY END USER, 20142022 (THOUSAND)
TABLE 4 GLOBAL IVF MARKET, BY END USER, 20142022 ($MILLION)
TABLE 5 GLOBAL IVF MARKET, BY CYCLE TYPE, 20142022 (THOUSAND)
TABLE 6 GLOBAL IVF MARKET, BY CYCLE TYPE, 20142022 ($MILLION)
TABLE 7 IVF SUCCESS RATES BASED ON AGE
TABLE 8 NORTH AMERICAN IVF MARKET, BY COUNTRY, 20142022 (THOUSAND)
TABLE 9 NORTH AMERICAN IVF MARKET, BY COUNTRY, 20142022 ($MILLION)
TABLE 10 U.S. IVF MARKET, VOLUME AND VALUE, 20142022 (THOUSAND AND $MILLION)
TABLE 11 NUMBER OF FERTILITY CLINICS IN U.S. (2015)
TABLE 12 U.S. IVF MARKET, BY END USER, 20142022 (THOUSAND)
TABLE 13 UNITED STATES IVF MARKET, BY END USERS, 2014 2022 ($MILLION)
TABLE 14 U.S. IVF MARKET BY CYCLE TYPE, 20142022 ($MILLION)
TABLE 15 U.S. IVF MARKET, BY CYCLE TYPE, 20142022 (THOUSAND)
TABLE 16 FERTILITY AND GYNECOLOGY CENTER MONTEREY BAY IVF BUSINESS OVERVIEW
TABLE 17 SNAPSHOT OF FERTILITY AND GYNECOLOGY CENTER MONTEREY BAY
TABLE 18 CONCEPTIONS REPRODUCTIVE ASSOCIATES BUSINESS OVERVIEW
TABLE 19 SNAPSHOT OF CONCEPTIONS REPRODUCTIVE ASSOCIATES
TABLE 20 SERVY MASSEY FERTILITY INSTITUTE BUSINESS OVERVIEW
TABLE 21 SNAPSHOT OF SERVY MASSEY FERTILITY INSTITUTE
TABLE 22 SHER INSTITUTE FOR REPRODUCTIVE MEDICINE (SIRM): BUSINESS OVERVIEW
TABLE 23 SNAPSHOT OF INSTITUTE FOR REPRODUCTIVE MEDICINE (SIRM)
TABLE 24 CARDONE REPRODUCTIVE MEDICINE & INFERTILITY: BUSINESS OVERVIEW
TABLE 25 SNAPSHOT OF CARDONE REPRODUCTIVE MEDICINE & INFERTILITY
TABLE 26 FERTILITY CENTER OF SAN ANTONIO: BUSINESS OVERVIEW
TABLE 27 SNAPSHOT OF FERTILITY CENTER OF SAN ANTONIO
TABLE 28 HOUSTON FERTILITY CENTER: BUSINESS OVERVIEW
TABLE 29 SNAPSHOT OF HOUSTON FERTILITY CENTER
TABLE 30 NEW HOPE FERTILITY CENTER BUSINESS OVERVIEW
TABLE 31 SNAPSHOT OF HOUSTON FERTILITY CENTER
TABLE 32 REPRODUCTIVE MEDICINE ASSOCIATES OF NEW JERSEY BUSINESS OVERVIEW
TABLE 33 SNAPSHOT OF HOUSTON FERTILITY CENTER
TABLE 34 CANADIAN IVF MARKET, VOLUME AND VALUE, 20142022 (THOUSAND AND $MILLION)
TABLE 35 CANADIAN IVF MARKET, BY END USER, 20142022 (THOUSAND)
TABLE 36 CANADIAN IVF MARKET BY END USERS, 20142022 ($MILLION)
TABLE 37 CANADIAN IVF MARKET, BY CYCLE TYPE, 20142022 ($MILLION)
TABLE 38 CANADIAN IVF MARKET BY CYCLE TYPE, 20142022 (THOUSAND)
TABLE 39 BUSINESS OVERVIEW
TABLE 40 SNAPSHOT OF TORONTO CENTRE FOR ADVANCED REPRODUCTIVE TECHNOLOGY LTD.
TABLE 41 FERTILITY TREATMENT CENTER: BUSINESS OVERVIEW
TABLE 42 SNAPSHOT OF FERTILITY TREATMENT CENTER
TABLE 43 FERTILITY TREATMENT CENTER BUSINESS OVERVIEW
TABLE 44 SNAPSHOT OF FERTILITY TREATMENT CENTER
TABLE 45 MEXICAN IVF MARKET, VOLUME AND VALUE, 20142022 (THOUSAND AND $MILLION)
TABLE 46 MEXICAN IVF MARKET, BY END USER, 20142022 (THOUSAND)
TABLE 47 MEXICAN IVF MARKET, BY END USER, 20142022 ($MILLION)
TABLE 48 MEXICAN IVF MARKET, BY CYCLE TYPE, 20142022 ($MILLION)
TABLE 49 MEXICAN IVF MARKET, BY CYCLE TYPE, 20142022 (THOUSAND)
TABLE 50 LIV FERTILITY CENTER IN PUERTO VALLARTA: BUSINESS OVERVIEW
TABLE 51 SNAPSHOT OF FERTILITY TREATMENT CENTER
TABLE 52 BIOFERTILITY CENTER IN GUDALAJARA: BUSINESS OVERVIEW
TABLE 53 SNAPSHOT OF FERTILITY TREATMENT CENTER
TABLE 54 EUROPE: IVF SERVICE MARKET, BY COUNTRY, 20142022 (THOUSAND)
TABLE 55 EUROPE: IVF MARKET, BY COUNTRY, 20142022 ($MILLION)
TABLE 56 GERMANY: IVF SERVICE MARKET, VOLUME & VALUE, 20142022 (THOUSAND & $MILLION)
TABLE 57 GERMANY: IVF MARKET, BY END USER, 20142022 (THOUSAND)
TABLE 58 GERMANY: IVF MARKET BY END USER, 20142022 ($MILLION)
TABLE 59 GERMANY: IVF MARKET VALUE, BY CYCLE TYPE, 20142022 ($MILLION)
TABLE 60 GERMANY: IVF MARKET VOLUME, BY CYCLE TYPE, 20142022 (THOUSAND)
TABLE 61 HEIDELBERG UNIVERSITY HOSPITAL BUSINESS OVERVIEW
TABLE 62 SNAPSHOT OF HEIDELBERG UNIVERSITY HOSPITAL
TABLE 63 KLINIKUM STUTTGART BUSINESS OVERVIEW
TABLE 64 COMPANY SNAPSHOT
TABLE 65 DRK KLINIKEN BERLIN BUSINESS OVERVIEW
TABLE 66 SNAPSHOT OF DRK KLINIKEN BERLIN
TABLE 67 UNIVERSITY MEDICAL CENTER FREIBURG BUSINESS OVERVIEW
TABLE 68 SNAPSHOT OF UNIVERSITY MEDICAL CENTER FREIBURG
TABLE 69 FRANCE: IVF MARKET, VOLUME & VALUE, 20142022 (THOUSAND, $MILLION)
TABLE 70 FRANCE: IVF MARKET, BY END USER, 20142022 (THOUSAND)
TABLE 71 FRANCE: IVF MARKET, BY END USER, 20142022 ($MILLION)
TABLE 72 FRANCE: IVF MARKET, BY CYCLE TYPE, 20142022 ($MILLION)
TABLE 73 FRANCE: IVF MARKET, BY CYCLE TYPE, 20142022 (THOUSAND)
TABLE 74 CLINIQUE DE LA MUETTE BUSINESS OVERVIEW
TABLE 75 SNAPSHOT OF CLINIQUE DE LA MUETTE
TABLE 76 HOPITAL DES METALLURGISTS, HOPITAL COCHIN BUSINESS OVERVIEW
TABLE 77 SNAPSHOT OF HOPITAL DES METALLURGISTS, HOPITAL COCHIN
TABLE 78 IVF CYCLES BY VARIOUS AGE GROUPS, UK, 2015
TABLE 79 PROPORTION OF IVF CYCLES USING FRESH & FROZEN EGGS, UK, 20102011
TABLE 80 IVF SUCCESS RATES IN UK (AS PER NHS), 2015
TABLE 81 REGIONAL IVF CLINICS AND TOTAL NUMBER OF WOMEN TREATED, UK, 2015
TABLE 82 UK IVF MARKET, VOLUME & VALUE, 20142022 (THOUSAND, $MILLION)
TABLE 83 UK IVF MARKET, BY END USER, 20142022 (THOUSAND)
TABLE 84 UK IVF MARKET, BY END USER, 20142022 ($MILLION)
TABLE 85 UK IVF MARKET, BY CYCLE TYPE, 20142022 ($MILLION)
TABLE 86 UK IVF MARKET, BY CYCLE TYPE, 20142022 (THOUSAND)
TABLE 87 LISTER FERTILITY CLINIC BUSINESS OVERVIEW
TABLE 88 COMPANY SNAPSHOT
TABLE 89 THE BRIDGE CENTER BUSINESS OVERVIEW
TABLE 90 SNAPSHOT OF THE BRIDGE CENTER
TABLE 91 CHELSEA AND WESTMINSTER HOSPITAL BUSINESS OVERVIEW
TABLE 92 SNAPSHOT OF CHELSEA AND WESTMINSTER HOSPITAL
TABLE 93 ITALY: IVF MARKET, VOLUME & VALUE, 20142022 (THOUSAND, $MILLION)
TABLE 94 ITALY: IVF MARKET BY END USER, 20142022 ($MILLION)
TABLE 95 ITALY: IVF MARKET, BY END USER, 20142022 (THOUSAND)
TABLE 96 ITALY: IVF MARKET, BY CYCLE TYPE, 20142022 ($MILLION)
TABLE 97 ITALY: IVF MARKET BY CYCLE TYPE, 20142022 (THOUSAND)
TABLE 98 SPAIN: IVF MARKET, VOLUME & VALUE, 20142022 (THOUSAND, $MILLION)
TABLE 99 SPAIN: IVF MARKET, BY END USER, 20142022 ($MILLION)
TABLE 100 SPAIN: IVF MARKET, BY END USER, 20142022 (THOUSAND)
TABLE 101 SPAIN: IVF MARKET BY CYCLE TYPE, 20142022 ($MILLION)
TABLE 102 SPAIN: IVF MARKET BY CYCLE TYPE, 20142022 (THOUSAND)
TABLE 103 DENMARK: IVF MARKET, VOLUME & VALUE, 20142022 (THOUSAND, $MILLION)
TABLE 104 DENMARK: IVF MARKET, BY END USER, 20142022 ($MILLION)
TABLE 105 DENMARK: IVF MARKET, BY END USER, 20142022 (THOUSAND)
TABLE 106 DENMARK: IVF MARKET, BY CYCLE TYPE, 20142022 ($MILLION)
TABLE 107 DENMARK: IVF MARKET, BY CYCLE TYPE, 20142022 (THOUSAND)
TABLE 108 RUSSIA: IVF MARKET, VOLUME & VALUE, 20142022 (THOUSAND, $MILLION)
TABLE 109 RUSSIA: IVF MARKET, BY END USER, 20142022 ($MILLION)
TABLE 110 RUSSIA: IVF MARKET, BY END USER, 20142022 (THOUSAND)
TABLE 111 RUSSIA: IVF MARKET, BY CYCLE TYPE, 20142022 ($MILLION)
TABLE 112 RUSSIA: IVF MARKET, BY CYCLE TYPE, 20142022 (THOUSAND)
TABLE 113 REST OF EUROPE: IVF MARKET, VOLUME & VALUE, 20142022 (THOUSAND, $MILLION)
TABLE 114 REST OF EUROPE: IVF MARKET REVENUE BY END USER, 20142022 ($MILLION)
TABLE 115 REST OF EUROPE: IVF CYCLES BY END USER, 20142022 (THOUSAND)
TABLE 116 ASIA-PACIFIC IVF MARKET, BY COUNTRY, 20142022 (THOUSAND)
TABLE 117 ASIA-PACIFIC: IVF MARKET, BY COUNTRY, 20142022 ($MILLION)
TABLE 118 INDIA: IVF MARKET, VOLUME & VALUE, 20142022 (THOUSAND, $MILLION)
TABLE 119 INDIA: IVF MARKET, BY END USER, 20142022 (THOUSAND)
TABLE 120 INDIA: IVF MARKET, BY END USERS, 20142022 ($MILLION)
TABLE 121 INDIA: IVF MARKET, BY CYCLE TYPE, 20142022 ($MILLION)
TABLE 122 INDIA: IVF MARKET BY CYCLE TYPE, 20142022 (THOUSAND)
TABLE 123 BOURN HALL BUSINESS OVERVIEW
TABLE 124 SOUTHEND FERTILITY AND IVF CENTRE BUSINESS OVERVIEW
TABLE 125 MORPHEUS IVF FERTILITY CENTER BUSINESS OVERVIEW
TABLE 126 BLOOM FERTILITY CENTER BUSINESS OVERVIEW
TABLE 127 MANIPAL ANKUR BUSINESS OVERVIEW
TABLE 128 CLOUDNINE BUSINESS OVERVIEW
TABLE 129 NOVA IVI FERTILITY BUSINESS OVERVIEW
TABLE 130 CHINA: IVF MARKET, VOLUME & VALUE, 20142022 (THOUSAND $MILLION)
TABLE 131 CHINA: IVF MARKET, BY END USER, 20142022 (THOUSAND)
TABLE 132 CHINA: IVF MARKET BY END USER, 20142022 ($MILLION)
TABLE 133 CHINA: IVF MARKET, BY CYCLE TYPE, 20142022 ($MILLION)
TABLE 134 CHINA: IVF MARKET, BY CYCLE TYPE, 20142022 (THOUSAND)
TABLE 135 REPRODUCTIVE AND GENETIC HOSPITAL CITIC-XIANGYA, BUSINESS OVERVIEW
TABLE 136 SHENYANG HOSPITAL BUSINESS OVERVIE
TABLE 137 SHANDONG PROVINCIAL HOSPITAL BUSINESS OVERVIEW
TABLE 138 CENTRE FOR REPRODUCTIVE MEDICINE, BUSINESS OVERVIEW
TABLE 139 JAPAN: IVF MARKET, VOLUME AND VALUE, 20142022 (THOUSAND, $MILLION)
TABLE 140 JAPAN: IVF MARKET, BY END USER, 20142022 (THOUSAND)
TABLE 141 JAPAN: IVF MARKET, BY END USER, 20142022 ($MILLION)
TABLE 142 JAPAN: IVF MARKET, BY CYCLE TYPE, 20142022 ($MILLION)
TABLE 143 JAPAN: IVF MARKET, BY CYCLE TYPE, 20142022 (THOUSAND)
TABLE 144 EMD SERONO INC. BUSINESS OVERVIEW
TABLE 145 SNAPSHOT OF EMD SERONO INC.
TABLE 146 IVF NAMBA CLINIC BUSINESS OVERVIEW
TABLE 147 IWAKI WOMENS CLINIC BUSINESS OVERVIEW
TABLE 148 SANNO HOSPITAL BUSINESS OVERVIEW
TABLE 149 AUSTRALIA: IVF MARKET, VOLUME AND VALUE, 20142022 (THOUSAND, $MILLION)
TABLE 150 AUSTRALIA: IVF MARKET, BY END USER, 20142022 (THOUSAND)
TABLE 151 AUSTRALIA: IVF MARKET, BY END USER, 20142022 ($MILLION)
TABLE 152 AUSTRALIA: IVF MARKET, BY CYCLE TYPE, 20142022 ($MILLION)
TABLE 153 AUSTRALIA: IVF MARKET, BY CYCLE TYPE, 2014-2022 (THOUSAND)
TABLE 154 GENEA BIOMEDX TECHNOLOGIES BUSINESS OVERVIEW
TABLE 155 SNAPSHOT OF GENEA BIOMEDX TECHNOLOGIES
TABLE 156 THERMO FISHER SCIENTIFIC INC. BUSINESS OVERVIEW
TABLE 157 SNAPSHOT OF THERMO FISHER SCIENTIFIC INC.
TABLE 158 VIRTUS HEALTH BUSINESS OVERVIEW
TABLE 159 MONASH IVF BUSINESS OVERVIEW
TABLE 160 CITY FERTILITY BUSINESS OVERVIEW
TABLE 161 FLINDERS FERTILITY BUSINESS OVERVIEW
TABLE 162 NEW ZEALAND: IVF MARKET, VOLUME AND VALUE, 20142022 (THOUSAND, $MILLION)
TABLE 163 NEW ZEALAND: IVF MARKET, BY END USER, 20142022 ($MILLION)
TABLE 164 NEW ZEALAND: IVF MARKET, BY END USER, 20142022 (THOUSAND)
TABLE 165 NEW ZEALAND: IVF MARKET, BY CYCLE TYPE, 20142022 ($MILLION)
TABLE 166 NEW ZEALAND: IVF MARKET, BY CYCLE TYPE, 20142022 (THOUSAND)
TABLE 167 KOREA: IVF MARKET, VOLUME AND VALUE, 20142022 (THOUSAND, $MILLION)
TABLE 168 KOREA: IVF MARKET, BY END USER, 20142022 ($MILLION)
TABLE 169 KOREA: IVF MARKET, BY END USER, 20142022 (THOUSAND)
TABLE 170 KOREA: IVF MARKET, BY CYCLE TYPE, 20142022 ($MILLION)
TABLE 171 KOREA: IVF MARKET, BY CYCLE TYPE, 20142022 (THOUSAND)
TABLE 172 THAILAND: IVF MARKET, VOLUME AND VALUE, 20142022 (THOUSAND, $MILLION)
TABLE 173 THAILAND: IVF MARKET, BY END USER, 20142022 ($MILLION)
TABLE 174 THAILAND: IVF MARKET, BY END USER, 20142022 (THOUSAND)
TABLE 175 THAILAND: IVF MARKET, BY CYCLE TYPE, 20142022 ($MILLION)
TABLE 176 THAILAND: IVF MARKET, BY CYCLE TYPE, 20142022 (THOUSAND)
TABLE 177 REST OF ASIA-PACIFIC: IVF MARKET, VOLUME AND VALUE, 20142022 (THOUSAND, $MILLION)
TABLE 178 REST OF ASIA-PACIFIC IVF MARKET, BY END USER, 20142022 ($MILLION)
TABLE 179 REST OF ASIA-PACIFIC: IVF MARKET, BY END USER, 20142022 (THOUSAND)
TABLE 180 LAMEA IVF MARKET, BY COUNTRY, 20142022 (THOUSAND)
TABLE 181 LAMEA IVF MARKET, BY COUNTRY, 20142022 ($MILLION)
TABLE 182 LATIN AMERICA: IVF MARKET, VOLUME AND VALUE, 20142022 (THOUSAND, $MILLION)
TABLE 183 LATIN AMERICA: IVF MARKET, BY END USER, 20142022 (THOUSAND)
TABLE 184 LATIN AMERICA: IVF MARKET, BY END USER, 20142022 ($MILLION)
TABLE 185 LATIN AMERICA: IVF MARKET, BY CYCLE TYPE, 20142022 ($MILLION)
TABLE 186 LATIN AMERICA: IVF MARKET, BY CYCLE TYPE, 20142022 (THOUSAND)
TABLE 187 CLINICA ANGLO AMERICANA BUSINESS OVERVIEW
TABLE 188 SNAPSHOT OF CLINICA ANGLO AMERICANA
TABLE 189 IVF PANAMA CENTRO DE REPRODUCCION PUNTA PACIFICA BUSINESS OVERVIEW
TABLE 190 SNAPSHOT OF IVF PANAMA CENTRO DE REPRODUCCION PUNTA PACIFICA
TABLE 191 INSAMER BUSINESS OVERVIEW
TABLE 192 COMPANY SNAPSHOT
TABLE 193 ALMATER HOSPITAL BUSINESS OVERVIEW
TABLE 194 COMPANY SNAPSHOT
TABLE 195 SAN FERNANDO HOSPITAL BUSINESS OVERVIEW
TABLE 196 COMPANY SNAPSHOT
TABLE 197 MIDDLE EAST: IVF MARKET, VOLUME AND VALUE, 20142022 (THOUSAND, $MILLION)
TABLE 198 MIDDLE EAST: IVF MARKET, BY END USER, 20142022 (THOUSAND)
TABLE 199 MIDDLE EAST: IVF MARKET, BY END USER, 20142022 ($MILLION)
TABLE 200 MIDDLE EAST: IVF MARKET, BY CYCLE TYPE, 20142022 ($MILLION)
TABLE 201 MIDDLE EAST: IVF MARKET BY CYCLE TYPE, 20142022 (THOUSAND)
TABLE 202 CYPRUS IVF CENTRE BUSINESS OVERVIEW
TABLE 203 COMPANY SNAPSHOT
TABLE 204 AL BUSHRA MEDICAL SPECIALTY COMPLEX BUSINESS OVERVIEW
TABLE 205 COMPANY OF AL BUSHRA MEDICAL SPECIALTY COMPLEX
TABLE 206 REPRODUCTIVE MEDICINE UNIT AT CORNICHE HOSPITAL BUSINESS OVERVIEW
TABLE 207 SNAPSHOT OF REPRODUCTIVE MEDICINE UNIT AT CORNICHE HOSPITAL
TABLE 208 TRAKYA UNIVERSITY HOSPITAL ART CENTER BUSINESS OVERVIEW
TABLE 209 SNAPSHOT OF TRAKYA UNIVERSITY HOSPITAL ART CENTER
TABLE 210 AFRICA: IVF MARKET, VOLUME AND VALUE, 20142022 (THOUSAND, $MILLION)
TABLE 211 AFRICA: IVF MARKET, BY END USER, 20142022 (THOUSAND)
TABLE 212 AFRICA: IVF MARKET, BY END USER, 20142022 ($MILLION)
TABLE 213 AFRICA: IVF MARKET, BY CYCLE TYPE, 20142022 ($MILLION)
TABLE 214 AFRICA: IVF MARKET, BY CYCLE TYPE, 20142022 (THOUSAND)
TABLE 215 LIFESURE FERTILITY & GYNAECOLOGY CENTRE BUSINESS OVERVIEW
TABLE 216 COMPANY SNAPSHOT
TABLE 217 BETHANY WOMEN AND FAMILY HOSPITAL BUSINESS OVERVIEW
TABLE 218 COMPANY SNAPSHOT
TABLE 219 BIOART FERTILITY CENTRE BUSINESS OVERVIEW
TABLE 220 COMPANY SNAPSHOT
TABLE 221 DEL INTERNATIONAL HOSPITAL & FERTILITY CENTRE BUSINESS OVERVIEW
TABLE 222 COMPANY SNAPSHOT
TABLE 223 GIFT OV LIFE BUSINESS OVERVIEW
TABLE 224 COMPANY SNAPSHOT
TABLE 225 DURBAN FERTILITY CLINIC BUSINESS OVERVIEW
TABLE 226 COMPANY SNAPSHOT
TABLE 227 CAPE FERTILITY CLINIC BUSINESS OVERVIEW
TABLE 228 COMPANY SNAPSHOT

...
Publisher Name : Allied Market Research

SIMILAR MARKET STUDIES

Please Select Format
Single User :- US $ 6720
Five User:- US $ 8160
Enterprise User:- US $ 11850
Data Pack :- US $ 5820

NEED MORE INFORMATION
Contact us
Call us +1-971-202-1575
--- or ---
help@bigmarketresearch.com
WHY BIG MARKET RESEARCH
With high quality and penned to perfection, Big Market Research is an exclusive online market to get best market research reports for your business needs and strategies. We recommend you to stop browsing as soon as you discover our website. This is because we firmly believe that once you reach here; all your business concerns will be addressed.

We have a huge collection of market research report from numerous filed which will provide you with all the necessary solution. We make sure that reports that we sell are true in context, have a quality that is unrivaled, fully integrated with equal spread of opinion. They will give you proper insights into different opportunities one may locate for their start-up pr expansion.

Let your qualms and concern be sidelined through our high end syndicated as well as customized reports.
Top